Back to LAZARD ASSET MANAGEMENT LLC LAZARD ASSET MANAGEMENT LLC

SRNESRNE
8 quarters

Position history for LAZARD ASSET MANAGEMENT LLCLAZARD ASSET MANAGEMENT LLC's holdings in Sorrento Therapeutics Inc

LAZARD ASSET MANAGEMENT LLC previously held 0 shares of SRNE (Sorrento Therapeutics Inc), worth $0 as of 2023-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$53,000

Total Shares Change

-29,009

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q1
Latest
Exited
0
-100.0%
$00.0%$0.37
0
2022-Q4
New
40,229
-
$35,0000.0%$0.89
30
2022-Q3
Exited
0
-100.0%
$00.0%$1.58
0
2022-Q2
New
39,498
-
$79,0000.0%$1.99
30
2020-Q4
Exited
0
-100.0%
$00.0%$7.24
0
2020-Q3
Decreased
1,787
-93.3%
$19,0000.0%$11.60
0
2020-Q2
Decreased
26,596
-8.3%
$167,0000.0%$6.11
0
2020-Q1
New
29,009
-
$53,0000.0%$1.85
29

Other major holders of SRNE: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used